Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study
Geoffrey McKee1, Zahid A Butt1,2, Stanley Wong1,2
1School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Insights
Understanding co-infections like Hepatitis B, C, and HIV is crucial. This study analyzed population data to find unique risk factors for different co-infection groups, informing targeted health services.
Area of Science:
- Infectious Diseases
- Epidemiology
- Public Health
Background:
- Limited data exist on Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Human Immunodeficiency Virus (HIV) co-infections and triple infections.
- Population-level characterization of these co-infections is essential for understanding unique predisposing factors.
Purpose of the Study:
- To characterize the co-occurrence of HIV, HBV, and HCV infections in British Columbia.
- To identify distinct patterns of predisposing factors associated with various co-infection subgroups.
Main Methods:
- Analysis of the BC Hepatitis Testers Cohort (1992-2013) and provincial registries.
- Classification of individuals into negative, mono-infection, and co-infection groups (HIV, HBV, HCV).
- Multivariate multinomial logistic regression to assess associations between risk factors (e.g., injection drug use, sexual orientation) and co-infection groups.
Main Results:
- Over 1.3 million individuals analyzed; 100,699 had at least one infection.
- Monoinfections were most common (90.8%), followed by HBV/HCV (4.0%), HCV/HIV (3.4%), HBV/HIV (0.7%), and HBV/HCV/HIV (1.2%).
- Men who have sex with men (MSM) showed higher odds of HIV co-infections, especially HBV/HIV (OR 6.8). Injection drug use strongly correlated with triple infection (OR 64.19) and HIV/HCV (OR 23.23).
Conclusions:
- Syndemics of substance use, sexual practices, mental illness, and socioeconomic factors interact with co-infections.
- Distinct population groups exhibit unique syndemic profiles.
- Health services require tailored composition and context to address the specific needs of each population group effectively.
Background:
Limited data are available on HBV, HCV, and HIV co-infections and triple infection. We characterized co-occurrence of HIV, HBV, and HCV infections at the population level in British Columbia (BC) to identify patterns of predisposing factors unique to co-infection subgroups.
Methods:
We analyzed data from the BC Hepatitis Testers Cohort, which includes all individuals tested for HCV or HIV in BC between 1992 and 2013, or included in provincial public health registries of HIV, HCV, HBV, and active tuberculosis. Individuals were classified as negative, mono-, and co-infection groups based on HIV, HBV, and HCV status. We evaluated associations between risk factors (injection drug use, sexual orientation etc.) and co-infection groups using multivariate multinomial logistic regression.
Findings:
Of a total of 1,376,989 individuals included in the analysis, 1,276,290 were negative and 100,699 were positive for HIV, HBV, and/or HCV. Most cases (91,399, 90.8%) were mono-infected, while 3991 (4.0%) had HBV/HCV, 670 HBV/HIV (0.7%), 3459 HCV/HIV (3.4%), and 1180 HBV/HCV/HIV (1.2%) co-infection. Risk factor and demographic distribution varied across co-infection categories. MSM classification was associated with higher odds of all HIV co-infection groups, particularly HBV/HIV (OR 6.8; 95% CI: 5.6, 8.27), while injection drug use was most strongly associated with triple infection (OR 64.19; 95% CI: 55.11, 74.77) and HIV/HCV (OR 23.23; 95% CI: 21.32, 25.31).
Interpretation:
Syndemics of substance use, sexual practices, mental illness, socioeconomic marginalization, and co-infections differ among population groups, highlighting avenues for optimal composition and context for health services to meet each population's unique needs.
Funding:
BC Centre for Disease Control and Canadian Institutes of Health Research.
Related Concept Videos
What is Population Genetics?
Conservation of Small Populations
Population Growth
What are Populations and Communities?
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Conservation of Declining Populations


